Evidence map›Paper›PMID 42540498›Full record

ArticleiScience2026

Non-canonical NF-κB drives a fate switch from germinal center to early effector B cells.

Waqas Nawaz, Amos Fong, Miguel P Cardoso, Jing Tang, Jenny Zhao, Michael Y Li, Shinya Rai, Aidan Beresford, Waleed Alduaij, Merrill Boyle and 3 more

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Waqas NawazCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Amos FongCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Miguel P CardosoCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Jing TangCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Jenny ZhaoCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Michael Y LiCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Shinya RaiCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Aidan BeresfordCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Waleed AlduaijCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Merrill BoyleCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Christian SteidlCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
David W ScottCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Leandro VenturuttiCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The non-canonical (NC) NF-κB pathway controls peripheral B-cell survival and follicular organization, pointing to a regulatory role during active adaptive immune responses. Here, we show that NC NF-κB activity is selectively attenuated in human germinal center B cells (GCBs), the population required to generate high-affinity antibodies, while remaining elevated in effector B cells. Accordingly, enforced NC NF-κB activation in murine B cells resulted in near-complete loss of GCB and high-affinity antibody production following immunization. These effects were primarily driven by NC NF-κB-induced reshaping of the immune microenvironment: activated B cells secreted IL-10, triggering premature expansion of regulatory T cells, limiting T cell help, and suppressing germinal center responses. Blocking IL-10 signaling was sufficient to normalize the niche and restore GCB. Concurrently, NC NF-κB activation promoted rapid B-cell differentiation into low-affinity antibody-secreting cells. Together, these findings identify NC NF-κB as a tunable rheostat linking B-cell signaling, immune-niche control, and humoral immunity.

Indexed as

adaptive immunityB cellsgerminal centerIL-10non-canonical NF-κBplasma cellsregulatory T cellsvaccination

Identifiers

PMID42540498
PMCPMC13426217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.